Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Verve Therapeutics IncCommon Stock stock | $43.93

Learn how to easily invest in Verve Therapeutics IncCommon Stock stock.

Verve Therapeutics Inc. Common Stock is a biotechnology business based in the US. Verve Therapeutics IncCommon Stock shares (VERV) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Verve Therapeutics IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VERV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Verve Therapeutics IncCommon Stock stock price (NASDAQ: VERV)

Use our graph to track the performance of VERV stocks over time.

Verve Therapeutics IncCommon Stock shares at a glance

Information last updated 2021-10-10.
Latest market close$43.93
52-week range$29.50 - $78.00
50-day moving average $59.35
200-day moving average $55.86
Wall St. target price$72.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-25.50

Buy Verve Therapeutics IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Verve Therapeutics IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Verve Therapeutics IncCommon Stock price performance over time

Historical closes compared with the close of $43.93 from 2021-10-15

1 week (2021-10-08) -0.02%
1 month (2021-09-16) -37.13%
3 months (2021-07-16) -9.55%
6 months (2021-04-12) N/A
1 year (2020-10-12) N/A
2 years (2019-10-12) N/A
3 years (2018-10-12) N/A
5 years (2016-10-12) N/A

Verve Therapeutics IncCommon Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $8.46
Market capitalisation $2.1 billion

TTM: trailing 12 months

Shorting Verve Therapeutics IncCommon Stock shares

There are currently 1.9 million Verve Therapeutics IncCommon Stock shares held short by investors – that's known as Verve Therapeutics IncCommon Stock's "short interest". This figure is 1.5% up from 1.9 million last month.

There are a few different ways that this level of interest in shorting Verve Therapeutics IncCommon Stock shares can be evaluated.

Verve Therapeutics IncCommon Stock's "short interest ratio" (SIR)

Verve Therapeutics IncCommon Stock's "short interest ratio" (SIR) is the quantity of Verve Therapeutics IncCommon Stock shares currently shorted divided by the average quantity of Verve Therapeutics IncCommon Stock shares traded daily (recently around 311422.27722772). Verve Therapeutics IncCommon Stock's SIR currently stands at 6.06. In other words for every 100,000 Verve Therapeutics IncCommon Stock shares traded daily on the market, roughly 6060 shares are currently held short.

To gain some more context, you can compare Verve Therapeutics IncCommon Stock's short interest ratio against those of similar companies.

However Verve Therapeutics IncCommon Stock's short interest can also be evaluated against the total number of Verve Therapeutics IncCommon Stock shares, or, against the total number of tradable Verve Therapeutics IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Verve Therapeutics IncCommon Stock's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Verve Therapeutics IncCommon Stock shares in existence, roughly 40 shares are currently held short) or 0.0722% of the tradable shares (for every 100,000 tradable Verve Therapeutics IncCommon Stock shares, roughly 72 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Verve Therapeutics IncCommon Stock.

Find out more about how you can short Verve Therapeutics IncCommon Stock stock.

Verve Therapeutics IncCommon Stock share dividends

We're not expecting Verve Therapeutics IncCommon Stock to pay a dividend over the next 12 months.

Verve Therapeutics IncCommon Stock overview

Verve Therapeutics, Inc. , a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics; a development and option agreement with Acuitas Therapeutics, Inc. ; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc.

Frequently asked questions

What percentage of Verve Therapeutics IncCommon Stock is owned by insiders or institutions?
Currently 6.932% of Verve Therapeutics IncCommon Stock shares are held by insiders and 55.823% by institutions.
When does the fiscal year end for Verve Therapeutics IncCommon Stock?
Verve Therapeutics IncCommon Stock's fiscal year ends in December.
Where is Verve Therapeutics IncCommon Stock based?
Verve Therapeutics IncCommon Stock's address is: 500 Technology Square, Cambridge, MA, United States, 02139
What is Verve Therapeutics IncCommon Stock's ISIN number?
Verve Therapeutics IncCommon Stock's international securities identification number is: US92539P1012

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site